Skip to Main Content

Paper Details

Effective Anti-tumor Response by TIGIT Blockade Associated With FcγR Engagement and Myeloid Cell Activation.
Front Immunol
22
2020
Author NameAffiliation
Drake LafaceMerck & Co. Inc.
  • 1 - 1

Datasets

Release 1.2